← Back to PTGX

PROTAGONIST THERAPEUTICS INC financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 05/08/2026Mar 2026Filed 05/05/2026Sep 2025Filed 06/11/2025Jun 2025Filed 05/08/2026Mar 2025Filed 05/05/2026Sep 2024Filed 06/11/2025Jun 2024Filed 06/08/2025Mar 2024Filed 06/05/2025
$213$56$4.7$5.5$28$4.7$4.2$255
$163$3.8−$39−$35−$12−$33−$31$207
$2.29$0.05−$0.62−$0.55−$0.19−$0.54−$0.50$3.26
7170646463626164

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.